Related Experiment Video
Updated: Jan 7, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
26.4K
Methylphenidate reorganizes cortical hierarchy through dopaminergic modulation
Dardo Tomasi1, Peter Manza2,3, Şükrü Barış Demiral2
1National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. dardo.tomasi@nih.gov.
Nature Communications
|December 13, 2025
Summary
Methylphenidate (MP) compresses the brain's functional hierarchy, altering neural communication. This dopamine-driven reorganization links to improved attention and individual differences in receptor availability.
Area of Science:
- Neuroscience
- Cognitive Neuroscience
- Neuroimaging
Background:
- Dopaminergic signaling influences brain network architecture along a sensorimotor to association cortex gradient.
- The effect of dopamine-enhancing psychostimulants like methylphenidate (MP) on this functional hierarchy and attention remains unclear.
Purpose of the Study:
- To investigate how methylphenidate (MP) affects the principal functional gradient of the human brain.
- To determine if MP-induced changes in cortical organization relate to attention and dopamine receptor availability.
Main Methods:
- Two double-blind, placebo-controlled studies in healthy adults (n=38, n=20) using PET and fMRI after MP administration.
- Validation in a large independent cohort from the Adolescent Brain Cognitive Development (ABCD) study (n=4,958).
Main Results:
- Methylphenidate (MP) consistently compressed the principal functional gradient, reducing segregation between sensory and association cortices.
- The extent of gradient compression correlated with individual striatal D1 and D2 receptor availability.
- MP-induced gradient compression in the inferior parietal cortex was associated with improved attention.
Conclusions:
- Dopamine-sensitive mechanisms underlie cortical functional reorganization that supports cognitive performance.
- Methylphenidate (MP) alters large-scale brain network organization, impacting attention through a gradient compression mechanism.
Related Concept Videos
01:25Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:30Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
724
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
724
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K